The Clinical Trials Program at New York's Northern Westchester Hospital Examines the Role of Nutrition in Prostate Cancer Progression

Share Article

The Clinical Trials Program at Northern Westchester Hospital is excited to present the "MEAL" study in prostate cancer.

The Clinical Trials Program at Northern Westchester Hospital is excited to present the “MEAL” study in prostate cancer.

True to its name, The MEAL [Men’s Eating and Living] study focuses on whether a man’s nutrition and diet contribute towards the progression of prostate cancer. Although a simple internet search will reveal plenty of information that states certain foods may decrease the incidence of prostate cancer, opinions are still mixed as to whether or not there is truth to the notion that diet plays a role in either the development of prostate cancer or the progression of prostate cancer once it has been diagnosed.

The MEAL study is designed for men who have been diagnosed with prostate cancer in New York and have been placed on active surveillance, also known as the watch and wait approach. These men have not had chemotherapy, radiation or surgery.

The MEAL study, sponsored by the National Cancer Institute, is designed to test whether a high-vegetable diet will lower risk for prostate cancer progression compared to a “standard” diet. NWH’s MEAL study is crucial to our understanding of the possible relation between consumption of food/food groups and the progression of prostate cancer.

It would be a huge step forward if, one day, doctors could tell a man that what he eats directly impacts the progression of his disease. This information might empower our patients to directly affect their health on a daily basis based on their eating habits.

The MEAL study will be overseen by the Medical Director of Clinical Trials at NWH, Dr. Joshua Fink.

The Clinical Trials Program at Northern Westchester Hospital is actively recruiting patients. For more information about joining the MEAL study, please call 914-666-1366 today.

Information about this trial can be found here.

About Northern Westchester Hospital
Northern Westchester Hospital (NWH) provides quality, patient centered care that is close to home through a unique combination of medical expertise, leading edge technology, and a commitment to humanity. Over 750 highly skilled physicians, state-of-the-art technology and professional staff of caregivers are all in place to ensure that you and your family receive treatment in a caring, respectful and nurturing environment.
NWH has established extensive internal quality measurements that surpass the standards defined by the Centers for Medicare & Medicaid Services (CMS) and the Hospital Quality Alliance (HQA). Our high quality standards help to ensure that the treatment you receive at NWH is among the best in the nation. For a complete list of our services, please visit
About Dr. Joshua Fink
Joshua Fink, MD is the Medical Director of the Clinical Trials Program at Northern Westchester Hospital in Mt. Kisco, NY. He received his medical degree from State University of New York Health Science Center in Brooklyn, NY. He received training from the George Washington University Medical Center in internal medicine, conducted his residency at Mount Sinai Medical Center in internal medicine, and received a fellowship at New York-Presbyterian Hospital in pulmonary & critical care medicine. He is board-certified in pulmonary disease and internal medicine and also speaks Spanish fluently.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mark Vincent
Visit website